The news isn't good from this metaanalysis published in last weeks NEJM
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
skip to main |
skip to sidebar
news stories and sundry information relevant to busy physicians and other health care providers interested in long term care.
No comments:
Post a Comment